PLUS1
29.87
0.57 (1.95%)
0.57 (1.95%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Pliant Therapeutics Inc | PLRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.57 | 1.95% | 29.87 | 29.2104 | 30.68 | 29.65 | 29.30 | 13:07:57 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 29.56 | 29.79 | 0.23 | 0.77% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 645 | 49,527 | $ 29.89 | $ 1,480,339 | 301,819 | 21.50 - 35.63 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:07:57 | 2 | $ 29.79 | USD |
Pliant Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.02B | 34.20M | 34.20M | $ 57.05M | $ 16.23M | -0.04 | 27.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Pliant Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 6/15/2020 | 16:41 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) |
| 6/05/2020 | 16:05 | PR Newswire (US) | Pliant Therapeutics Announces Closing of Initial Public.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PLRX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 30.46 | 35.63 | 28.5088 | 31.68 | 137,377 | -0.59 | -1.94% |
| 1 Month | 22.50 | 35.63 | 21.50 | 24.82 | 263,619 | 7.37 | 32.76% |
| 3 Months | 22.50 | 35.63 | 21.50 | 24.82 | 263,619 | 7.37 | 32.76% |
| 6 Months | 22.50 | 35.63 | 21.50 | 24.82 | 263,619 | 7.37 | 32.76% |
| 1 Year | 22.50 | 35.63 | 21.50 | 24.82 | 263,619 | 7.37 | 32.76% |
| 3 Years | 22.50 | 35.63 | 21.50 | 24.82 | 263,619 | 7.37 | 32.76% |
| 5 Years | 22.50 | 35.63 | 21.50 | 24.82 | 263,619 | 7.37 | 32.76% |
Pliant Therapeutics Description
| Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis. |
